STRUCTURE THERAPEUTICS INC (GPCR) Forecast, Price Target & Analyst Ratings

NASDAQ:GPCR • US86366E1064

Current stock price

53.48 USD
+3.31 (+6.6%)
At close:
53.55 USD
+0.07 (+0.13%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STRUCTURE THERAPEUTICS INC (GPCR).

Forecast Snapshot

Consensus Price Target

Price Target
$111.47
+ 108.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$111.47
Upside
+ 108.44%
From current price of $53.48 to mean target of $111.47, Based on 23 analyst forecasts
Low
$90.90
Median
$103.02
High
$152.25

Price Target Revisions

1 Month
1.19%
3 Months
18.20%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for GPCR. The average price target is 111.47 USD. This implies a price increase of 108.43% is expected in the next year compared to the current price of 53.48.
The average price target has been revised upward by 18.2% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GPCR Current Analyst RatingGPCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

GPCR Historical Analyst RatingsGPCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.22%
GPCR was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GPCR.
In the previous month the buy percentage consensus was at a similar level.
GPCR was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16HC Wainwright & Co.Maintains Buy -> Buy
2026-03-02HC Wainwright & Co.Maintains Buy -> Buy
2026-02-27CitizensMaintains Market Outperform -> Market Outperform
2026-01-22JP MorganMaintains Overweight -> Overweight
2026-01-20GuggenheimMaintains Buy -> Buy
2025-12-19HC Wainwright & Co.Maintains Buy -> Buy
2025-12-12CitizensMaintains Market Outperform -> Market Outperform
2025-12-12Morgan StanleyMaintains Overweight -> Overweight
2025-12-11JefferiesMaintains Buy -> Buy
2025-12-09Clear StreetMaintains Buy -> Buy
2025-12-09StifelMaintains Buy -> Buy
2025-12-09CitigroupMaintains Buy -> Buy
2025-08-07GuggenheimMaintains Buy -> Buy
2025-08-07JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-08-07HC Wainwright & Co.Maintains Buy -> Buy
2025-06-23Cantor FitzgeraldReiterate Overweight -> Overweight
2025-06-23JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-05-12HC Wainwright & Co.Maintains Buy -> Buy
2025-05-02CitigroupInitiate Buy
2025-04-22HC Wainwright & Co.Maintains Buy -> Buy
2025-02-28Citizens Capital MarketsMaintains Market Outperform -> Market Outperform
2025-02-28William BlairInitiate Outperform
2025-01-08StifelInitiate Buy
2024-12-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-19HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
55.63%
Number of Analysts
16

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-5.08%
EPS (3 Months)
12.46%

Next Earnings Summary

GPCR is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.36 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GPCR revenue by date.GPCR revenue by date.
N/AN/AN/A
397,538.78%		N/A
218.13%		N/A
62.20%		N/A
61.91%		N/A
54.96%		N/A
40.68%
EBITDA
YoY % growth
GPCR ebitda by date.GPCR ebitda by date.
-15.906M-37.624M
-136.54%		-52.284M
-38.96%		-102.48M
-96.01%		-157.236M
-53.43%		-185.476M
-17.96%		N/A
-100.38%		N/A
-12.78%		N/A
-10.85%		N/A
27.88%		N/A
189.09%		N/A
258.10%		N/A
97.19%		N/A
50.95%
EBIT
YoY % growth
GPCR ebit by date.GPCR ebit by date.
-15.906M-37.696M
-136.99%		-52.561M
-39.43%		-102.775M
-95.53%		-158.228M
-53.96%		-186.809M
-18.06%		N/A
-107.44%		N/A
-24.41%		N/A
3.21%		N/A
85.07%		N/A
601.30%		N/A
146.38%		N/A
94.85%		N/A
58.97%
Operating Margin
GPCR operating margin by date.GPCR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
GPCR eps by date.GPCR eps by date.
N/AN/AN/A-2.13
40.84%		-2.40
-12.68%		-4.22
-75.83%		N/A
58.48%		N/A
-23.42%		N/A
-3.06%		N/A
123.46%		N/A
321.46%		N/A
105.67%		N/A
69.33%		N/A
48.99%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.36
55.63%		-0.42
60.81%		-0.46
58.68%		-0.50
59.15%		-0.48
-33.21%		-0.51
-20.00%		-0.54
-18.46%		-0.58
-15.57%		-0.45
6.25%		-0.45
11.65%		-0.44
19.27%		-0.44
23.85%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-88.261M
-57.51%		-93.035M
-33.12%		-95.737M
-31.39%		-102.71M
-781.42%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-88.688M
-57.50%		-91.337M
-29.65%		-95.537M
-29.48%		-101.802M
-840.92%		-108.191M
-21.99%		-122.462M
-34.08%		-138.775M
-45.26%		-157.432M
-54.65%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GPCR Yearly Revenue VS EstimatesGPCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
GPCR Yearly EPS VS EstimatesGPCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.75%
EPS Next 5 Year
20.32%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-18.13%
EBIT Next 5 Year
25.06%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

STRUCTURE THERAPEUTICS INC / GPCR Forecast FAQ

What is the average price target for STRUCTURE THERAPEUTICS INC (GPCR) stock?

23 analysts have analysed GPCR and the average price target is 111.47 USD. This implies a price increase of 108.43% is expected in the next year compared to the current price of 53.48.

When does STRUCTURE THERAPEUTICS INC (GPCR) report earnings?

STRUCTURE THERAPEUTICS INC (GPCR) will report earnings on 2026-05-06, after the market close.

Can you provide the consensus estimates for STRUCTURE THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of STRUCTURE THERAPEUTICS INC (GPCR) is -0.36 USD and the consensus revenue estimate is 0 USD.

How many analysts cover STRUCTURE THERAPEUTICS INC (GPCR) stock?

The number of analysts covering STRUCTURE THERAPEUTICS INC (GPCR) is 23.